Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allarity Therapeutics, Inc. - Common stock (NQ: ALLR ) 1.350 -0.050 (-3.57%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 186,256 Open 1.410 Bid (Size) 1.320 (32) Ask (Size) 1.360 (12) Prev. Close 1.400 Today's Range 1.330 - 1.410 52wk Range 1.260 - 666.00 Shares Outstanding 198,742,643 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALLR November 09, 2024 From The Rosen Law Firm PA Via GlobeNewswire ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights November 08, 2024 From The Rosen Law Firm, P.A. Via Business Wire Performance YTD -99.59% -99.59% 1 Month -8.16% -8.16% 3 Month -69.45% -69.45% 6 Month -94.35% -94.35% 1 Year -99.52% -99.52% More News Read More The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR) November 08, 2024 From The Law Offices of Frank R. Cruz Via Business Wire DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics November 06, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm November 05, 2024 From Bragar Eagel & Squire Via GlobeNewswire DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Allarity Therapeutics to Contact Us to Have Their Losses Evaluated Today November 02, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics October 30, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Allarity, ZoomInfo, and Agenus and Encourages Investors to Contact the Firm October 29, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR October 26, 2024 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR October 23, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Agenus, and New Fortress and Encourages Investors to Contact the Firm October 22, 2024 From Bragar Eagel & Squire Via GlobeNewswire Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib October 22, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm October 16, 2024 From Bragar Eagel & Squire Via GlobeNewswire SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics October 16, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR October 13, 2024 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, A LEADING NATIONAL FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR October 10, 2024 From The Rosen Law Firm PA Via GlobeNewswire Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement October 10, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm October 09, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, SKILLED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR October 06, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm October 05, 2024 From Bragar Eagel & Squire Via GlobeNewswire Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program October 03, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, and New Fortress and Encourages Investors to Contact the Firm October 01, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR September 30, 2024 From The Rosen Law Firm PA Via GlobeNewswire ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! September 29, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Shareholder Rights Law Firm Robbins LLP Encourages Allarity Therapeutics, Inc. Stockholders with Large Losses to Contact the Firm for Information About the ALLR Securities Class Action September 27, 2024 From Robbins LLP Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
